Immune Response BioPharma, Inc. - Net Worth and Insider Trading

Immune Response BioPharma, Inc. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Immune Response BioPharma, Inc. owns 1 companies in total, including PDL BioPharma Inc (PDLI) .

Click here to see the complete history of Immune Response BioPharma, Inc.’s form 4 insider trades.

Insider Ownership Summary of Immune Response BioPharma, Inc.

Ticker	Comapny	Transaction Date	Type of Owner
PDLI	PDL BioPharma Inc	2015-05-17	other: Shareholder

Immune Response BioPharma, Inc. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Immune Response BioPharma, Inc. Ownership Network

Ownership Network List of Immune Response BioPharma, Inc.

No Data

Ownership Network Relation of Immune Response BioPharma, Inc.

Immune Response BioPharma, Inc. Owned Company Details

What does PDL BioPharma Inc do?

Who are the key executives at PDL BioPharma Inc?

Immune Response BioPharma, Inc. is the other: Shareholder of PDL BioPharma Inc. Other key executives at PDL BioPharma Inc include President and CEO Dominique Monnet , VP & Gen. Counsel & Secretary Christopher Lewis Stone , and VP Finance & CAO and Acting CFO Edward Imbrogno .

PDL BioPharma Inc (PDLI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PDL BioPharma Inc (PDLI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PDL BioPharma Inc (PDLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PDL BioPharma Inc (PDLI)'s detailed insider trading history can be found in Insider Trading Tracker table.

PDL BioPharma Inc Insider Transactions

No Available Data

Immune Response BioPharma, Inc. Mailing Address

Above is the net worth, insider trading, and ownership report for Immune Response BioPharma, Inc.. You might contact Immune Response BioPharma, Inc. via mailing address: 244 5th Avenue Suite 1727 New York Ny 10001.

Discussions on Immune Response BioPharma, Inc.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.